Clinical Trial Update: A Single-Center, Randomized, Open-Label, Two-Sequence, Two-Period, Crossover Study Comparing the Pharmacokinetics and Safety of Pyridostigmine Sustained-Release and Immediate-Release Tablets Following Single and Multiple Doses in Healthy Chinese Participants [Phase 1]

View source ↗

Summary

A single-center, randomized, open-label crossover Phase 1 study in healthy Chinese participants comparing pharmacokinetics and safety of pyridostigmine sustaine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• pyridostigmine immediate-release tablet (pyridostigmine)
• pyridostigmine sustained-release tablet (pyridostigmine)

Snippet

Sponsor: West China Second University Hospital | Conditions: Myasthenia Gravis, Pharmacokinetics | Phase 1 | Status: COMPLETED